Compare $CLDI vs $ONCO | Chartloom

Compare

$CLDI vs $ONCO

Calidi Biotherapeutics Inc · Onconetix Inc

CLDI

Calidi Biotherapeutics Inc

ONCO

Onconetix Inc

Compare $CLDI vs $ONCO

Comparing Calidi Biotherapeutics Inc and Onconetix Inc

CLDICalidi Biotherapeutics Inc

ONCOOnconetix Inc

CLDICalidi Biotherapeutics Inc

Market cap

$20M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-94.5%

52W performance

-96.0%

FCF yield

-89.7%

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDI

ONCO

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

ONCO

Onconetix Inc

Market Cap

CLDI$20M

ONCO$2M

Enterprise Value

CLDI$17M

ONCO$-3M

Price

CLDI$1.03

ONCO$0.62

P/E Ratio

CLDIN/A

ONCON/A

P/S Ratio

CLDI0.00x

ONCO3.79x

EV/Sales

CLDI0.00x

ONCO-5.18x

EV/EBITDA

CLDI0.00x

ONCO0.00x

P/B Ratio

CLDI1.27x

ONCO0.24x

P/FCF Ratio

CLDIN/A

ONCON/A

EV/FCF

CLDI-0.94x

ONCO0.32x

PEG Ratio

CLDIN/A

ONCON/A

Forward P/E (NTM)

CLDIN/A

ONCON/A

Forward P/S (NTM)

CLDIN/A

ONCON/A

Revenue (TTM)

CLDI$0

ONCO$646K

Revenue Growth (YoY)

CLDIN/A

ONCO-51.3%

Forward Rev Growth

CLDI0.0%

ONCO0.0%

Gross Margin (TTM)

CLDI0.0%

ONCO80.4%

Operating Margin (TTM)

CLDI0.0%

ONCO0.0%

EBITDA Margin (TTM)

CLDI0.0%

ONCO-1188.1%

Net Margin (TTM)

CLDI0.0%

ONCO-1578.8%

FCF Margin (TTM)

CLDIN/A

ONCO-1596.2%

Net Income (TTM)

CLDI$-23M

ONCO$-10M

FCF (TTM)

CLDI$-18M

ONCO$-10M

EPS (TTM)

CLDI-$265.03

ONCO-$4.55

ROE (TTM)

CLDI-37285.0%

ONCO-9194.0%

ROA (TTM)

CLDI-17613.0%

ONCO-5376.0%

ROIC (TTM)

CLDI-30694.0%

ONCO-9080.0%

Cash

CLDI$4M

ONCO$6M

Debt

CLDI$928K

ONCO$150K

Net Cash/Debt

CLDI$3M

ONCO$6M

Current Ratio (TTM)

CLDI1.68x

ONCO2.21x

Quick Ratio (TTM)

CLDI1.55x

ONCO2.04x

Debt/Equity (TTM)

CLDI0.30x

ONCO0.01x

Debt/Assets (TTM)

CLDI0.0%

ONCO0.0%

Interest Coverage (TTM)

CLDIN/A

ONCON/A

Net Debt/EBITDA (TTM)

CLDI0.00x

ONCO0.00x

Beta

CLDI1.37

ONCO2.60

52W Performance

CLDI-96.0%

ONCO-99.7%

YTD Performance

CLDI-94.5%

ONCO-99.2%

% from 52W High

CLDI-96.3%

ONCO-99.7%

% from 52W Low

CLDI4.5%

ONCO6.9%

Asset Turnover (TTM)

CLDI0.00x

ONCO0.03x

FCF Yield (TTM)

CLDI-89.7%

ONCO-420.9%

Earnings Yield (TTM)

CLDI-117.9%

ONCO-416.3%

Dividend Yield (TTM)

CLDIN/A

ONCON/A

Rule of 40

CLDI0.0

ONCO-1,647.5

EV/GP/RG

CLDIN/A

ONCON/A

Ticker research

View CLDI research View ONCO research

Metric	CLDI Calidi Biotherapeutics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$20M	$2M
Enterprise Value	$17M	$-3M
Price	$1.03	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.79x
EV/Sales	0.00x	-5.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$646K
Revenue Growth (YoY)	N/A	-51.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	80.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1188.1%
Net Margin (TTM)	0.0%	-1578.8%
FCF Margin (TTM)	N/A	-1596.2%
Net Income (TTM)	$-23M	$-10M
FCF (TTM)	$-18M	$-10M
EPS (TTM)	-$265.03	-$4.55
ROE (TTM)	-37285.0%	-9194.0%
ROA (TTM)	-17613.0%	-5376.0%
ROIC (TTM)	-30694.0%	-9080.0%
Financial Health
Cash	$4M	$6M
Debt	$928K	$150K
Net Cash/Debt	$3M	$6M
Current Ratio (TTM)	1.68x	2.21x
Quick Ratio (TTM)	1.55x	2.04x
Debt/Equity (TTM)	0.30x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	2.60
52W Performance	-96.0%	-99.7%
YTD Performance	-94.5%	-99.2%
% from 52W High	-96.3%	-99.7%
% from 52W Low	4.5%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.03x
FCF Yield (TTM)	-89.7%	-420.9%
Earnings Yield (TTM)	-117.9%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,647.5
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View ONCO research

Valuation

P/S Ratio

CLDI

0.00x

ONCO

3.79x

EV/FCF

CLDI

-0.94x

ONCO

0.32x

Growth & revenue

Revenue Growth TTM

ONCO

-51.3%

Forward Revenue Growth

CLDI

0.0%

ONCO

0.0%

Profitability & performance

Gross Margin

ONCO

80.4%

CLDI

0.0%

ROE

ONCO

-9194.0%

CLDI

-37285.0%

FCF Yield %

CLDI

-89.7%

ONCO

-420.9%

52-Week Performance

CLDI

-96.0%

ONCO

-99.7%

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

ONCO

Onconetix Inc

Market Cap

CLDI$20M

ONCO$2M

Enterprise Value

CLDI$17M

ONCO$-3M

Price

CLDI$1.03

ONCO$0.62

P/E Ratio

CLDIN/A

ONCON/A

P/S Ratio

CLDI0.00x

ONCO3.79x

EV/Sales

CLDI0.00x

ONCO-5.18x

EV/EBITDA

CLDI0.00x

ONCO0.00x

P/B Ratio

CLDI1.27x

ONCO0.24x

P/FCF Ratio

CLDIN/A

ONCON/A

EV/FCF

CLDI-0.94x

ONCO0.32x

PEG Ratio

CLDIN/A

ONCON/A

Forward P/E (NTM)

CLDIN/A

ONCON/A

Forward P/S (NTM)

CLDIN/A

ONCON/A

Revenue (TTM)

CLDI$0

ONCO$646K

Revenue Growth (YoY)

CLDIN/A

ONCO-51.3%

Forward Rev Growth

CLDI0.0%

ONCO0.0%

Gross Margin (TTM)

CLDI0.0%

ONCO80.4%

Operating Margin (TTM)

CLDI0.0%

ONCO0.0%

EBITDA Margin (TTM)

CLDI0.0%

ONCO-1188.1%

Net Margin (TTM)

CLDI0.0%

ONCO-1578.8%

FCF Margin (TTM)

CLDIN/A

ONCO-1596.2%

Net Income (TTM)

CLDI$-23M

ONCO$-10M

FCF (TTM)

CLDI$-18M

ONCO$-10M

EPS (TTM)

CLDI-$265.03

ONCO-$4.55

ROE (TTM)

CLDI-37285.0%

ONCO-9194.0%

ROA (TTM)

CLDI-17613.0%

ONCO-5376.0%

ROIC (TTM)

CLDI-30694.0%

ONCO-9080.0%

Cash

CLDI$4M

ONCO$6M

Debt

CLDI$928K

ONCO$150K

Net Cash/Debt

CLDI$3M

ONCO$6M

Current Ratio (TTM)

CLDI1.68x

ONCO2.21x

Quick Ratio (TTM)

CLDI1.55x

ONCO2.04x

Debt/Equity (TTM)

CLDI0.30x

ONCO0.01x

Debt/Assets (TTM)

CLDI0.0%

ONCO0.0%

Interest Coverage (TTM)

CLDIN/A

ONCON/A

Net Debt/EBITDA (TTM)

CLDI0.00x

ONCO0.00x

Beta

CLDI1.37

ONCO2.60

52W Performance

CLDI-96.0%

ONCO-99.7%

YTD Performance

CLDI-94.5%

ONCO-99.2%

% from 52W High

CLDI-96.3%

ONCO-99.7%

% from 52W Low

CLDI4.5%

ONCO6.9%

Asset Turnover (TTM)

CLDI0.00x

ONCO0.03x

FCF Yield (TTM)

CLDI-89.7%

ONCO-420.9%

Earnings Yield (TTM)

CLDI-117.9%

ONCO-416.3%

Dividend Yield (TTM)

CLDIN/A

ONCON/A

Rule of 40

CLDI0.0

ONCO-1,647.5

EV/GP/RG

CLDIN/A

ONCON/A

Ticker research

View CLDI research View ONCO research

Metric	CLDI Calidi Biotherapeutics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$20M	$2M
Enterprise Value	$17M	$-3M
Price	$1.03	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.79x
EV/Sales	0.00x	-5.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$646K
Revenue Growth (YoY)	N/A	-51.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	80.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1188.1%
Net Margin (TTM)	0.0%	-1578.8%
FCF Margin (TTM)	N/A	-1596.2%
Net Income (TTM)	$-23M	$-10M
FCF (TTM)	$-18M	$-10M
EPS (TTM)	-$265.03	-$4.55
ROE (TTM)	-37285.0%	-9194.0%
ROA (TTM)	-17613.0%	-5376.0%
ROIC (TTM)	-30694.0%	-9080.0%
Financial Health
Cash	$4M	$6M
Debt	$928K	$150K
Net Cash/Debt	$3M	$6M
Current Ratio (TTM)	1.68x	2.21x
Quick Ratio (TTM)	1.55x	2.04x
Debt/Equity (TTM)	0.30x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	2.60
52W Performance	-96.0%	-99.7%
YTD Performance	-94.5%	-99.2%
% from 52W High	-96.3%	-99.7%
% from 52W Low	4.5%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.03x
FCF Yield (TTM)	-89.7%	-420.9%
Earnings Yield (TTM)	-117.9%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,647.5
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View ONCO research